Funding Details
- Date Award
- May 13, 2024
- Vertical
- Therapeutics
- Funding URL
- View Funding Page
Company Info
- Traction
- None
- Organizations Involved
- None
- Founders
- Julie Rosser, Syed Faheem Ali
- Company Description
- Pregenerate is accelerating drug development and personalized medicine for arthritis with our novel tissue-on-a-chip technology. We use scaleable organ-on-a-chip models to understand how cartilage cells respond to inflammation. This technology will ultimately allow us to stratify patients into targeted treatment subgroups and even to tell each clinical patient what the best treatment is for his or her specific arthritis needs.
- Market
- Human Health
- Location
-
Austria
- Coinvestors
- None
Links